(Reuters) - July 30 - Diagnostic-test maker Cytyc Corp. reported a small rise in its second-quarter profit due to higher expenses.
Cytyc's revenue, however, jumped nearly 26 percent, as the company sold more surgical and diagnostic products in both its domestic and international markets. The Marlborough, Massachusetts-based company, which agreed to be acquired by Hologic Inc. for $6.2 billion, reported net income of $33.5 million, or 27 cents a share, compared with $31.7 million, or 27 cents a share, a year ago.
Read more at Reuters.com Market News
Cytyc's revenue, however, jumped nearly 26 percent, as the company sold more surgical and diagnostic products in both its domestic and international markets. The Marlborough, Massachusetts-based company, which agreed to be acquired by Hologic Inc. for $6.2 billion, reported net income of $33.5 million, or 27 cents a share, compared with $31.7 million, or 27 cents a share, a year ago.
Read more at Reuters.com Market News
No comments:
Post a Comment